Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
| Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes |
| Autore | Ylostalo Joni H |
| Pubbl/distr/stampa | Basel, : MDPI Books, 2022 |
| Descrizione fisica | 1 electronic resource (204 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
cell therapy
immunomodulation polyunsaturated fatty acid CD206 phagocytosis mesenchymal stem cells Vadadustat AKB-6548 preconditioning priming secretome chemotaxis Wharton’s jelly mesenchymal stem cells umbilical cord oxygen conditions secretory profile neuroprotection mesenchymal stromal cells 3D culture neurospheres spheroids pluripotency neural quiescence mesothelioma malignant pleural mesothelioma (MPM) liver cirrhosis placenta-derived mesenchymal stem cells WKYMVm combination therapy iPSC-derived MSCs iMSC secretome pre-conditioning angiogenesis IFN-γ hypoxia potentiation of iMSC efficacy nanofiber-hydrogel composite spinal cord injury inflammation macrophages secondary injury astrocytes axon growth adipose tissue-derived stem cells (ASCs) autophagy rapamycin 3-methyladenine immunosuppression exosome engineered cardiac patches adipose-derived stem cell paracrine potential osteogenic differentiation hepatocyte growth factor fibroblast growth factor 2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Enhancing Mesenchymal Stem Cells |
| Record Nr. | UNINA-9910595079403321 |
Ylostalo Joni H
|
||
| Basel, : MDPI Books, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Research of Pathogenesis and Novel Therapeutics in Arthritis
| Research of Pathogenesis and Novel Therapeutics in Arthritis |
| Autore | Tang Chih-Hsin |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (366 p.) |
| Soggetto non controllato |
receptor activator of nuclear factor ?B
infliximab tripterine triptolide osteoblast tumor necrosis factor-alpha synovial cell anti-arthritis biosimilars Epstein-Barr virus cytokines SOX9 parathyroid hormone nitric oxide rat etanercept angiogenesis glycosylation mitogen activated protein kinase Th9 lymphocytes rheumatoid arthritis IL-6 clodronate bone erosion mesenchymal stem cells collagen-induced arthritis biological gene expression inflammatory arthritis osteoarthritis fraxinellone nuclear factor kappa B messenger RNA inflammation miRNA disease-modifying adipokines WNT glycoprotein 42 miR-199a-5p proliferation next-generation sequencing collagen osteoarthritis (OA) experimental arthritis bone morphogenetic protein TNF-? computational modeling basic research osteoclast therapeutics certolizumab pegol chondrocytes progenitor cells adjuvant arthritis adalimumab triterpenoid sclareol TNF? fibroblast growth factor 2 antibodies osteoblasts molecular pathology Th17 immunology obesity visfatin articular cartilage autoimmune biomarkers celastrol MAPK disease pathways IL1? arthritis bioinformatics anticitrullinated peptide antibodies drug delivery system antagonists shared epitope pathology SMA- and MAD-related protein small-molecule inhibitor transforming growth factor ? mice golimumab spinal fusion antirheumatic drug early osteoarthritis stem cell rheumatoid factor therapeutic antibody bisphosphonate osteoclastogenesis interleukin spondyloarthropathies clinical translation therapy Traditional Chinese medicine chemokines structure cell signaling microRNA |
| ISBN | 3-03897-066-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910346843303321 |
|
Tang Chih-Hsin
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||